Italia markets close in 45 minutes

Pharming Group N.V. (0QCO.IL)

IOB - IOB Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
1,0200+0,0235 (+2,36%)
In data: 03:14PM GMT. Mercato aperto.
Schermo intero
Chiusura precedente0,9965
Aperto1,0110
Denaro0,9945 x 0
Lettera1,0450 x 0
Min-Max giorno1,0030 - 1,0250
Intervallo di 52 settimane0,9385 - 1,3120
Volume352.413
Media Volume1.149.083
Capitalizzazione799,53M
Beta (5 anni mensile)0,87
Rapporto PE (ttm)N/D
EPS (ttm)-0,0200
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Pharming Group to report third quarter 2023 financial results on October 26

    Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 EDT on October 26, 2023. To participate in the conference call, please register in advance using the link below. Once registered, dial-in informat

  • GlobeNewswire

    Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders

    Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Dr. Richard Peters as Non-Executive director for a period of four years. As a result, Dr. Peters succeeds Mr. Paul Sekhri as Chair of the Board of Directors with immediate effect. Deborah Jorn, Vice-Chair of the